INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $13.50 | 12,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 2,000 | $13.50 | 10,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 15,000 |
| Dec 11, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 1,432 |
| Dec 11, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 1,897 |
| Dec 11, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 1,861 |
| Dec 09, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 969 | -- | 19,352 |
| Dec 09, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,750 | -- | 21,102 |
| Dec 09, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- | 10,000 |
| Sep 24, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Bona fide gift | 50 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.